Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Regulatory News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TR-1: Notification of Major Interest in Shares

3 Aug 2012 17:35

For filings with the FSA include the annex For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer SILENCE THERAPEUTICSof existing shares to which voting rights are

PLCattached:ii

2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result

in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to Xqualifying financial instruments An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the

ROBERT KEITHnotification obligation:iii 4. Full name of shareholder(s) Rock ( Nominees) Limited (if different from 3.):iv

5. Date of the transaction and date on which the threshold is crossed or

02.08.12reached: v

6. Date on which issuer notified:

03.08.12

7. Threshold(s) that is/are crossed or

18%reached: vi, vii 8. Notified details:

A: Voting rights attached to shares viii, ix Class/type Situation previous Resulting situation after the triggering transaction of to the triggering shares transaction Number Number Number Number of voting % of voting rights x if possible of of of shares rights using Shares Voting the ISIN Rights Direct Direct xi Indirect Direct Indirect CODE xii GB0008433350 54,089,628 3.68% 254,089,628 254,089,628 17.33%

B: Qualifying Financial Instruments Resulting situation after the triggering transaction

Type of Expiration Exercise/ Number of voting % of voting financial date xiii Conversion Period xiv rights that may be rights instrument acquired if the instrument is exercised/ converted. C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction Type of Exercise price Expiration Exercise/ Number of voting rights % of voting rights financial date xvii Conversion instrument refers to xix, xx instrument period xviii Nominal Delta Spreadbet n/a n/a n/a 14,236,216 0.97% 0.97% Total (A+B+C) Number of voting rights Percentage of voting rights 268,325,844 18.30%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

Proxy Voting: 10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease

to hold:

12. Date on which proxy holder will cease to hold

voting rights: 13. Additional information: 14. Contact name: ROBERT KEITH

15. Contact telephone number:

0207 491 0581

Note: Annex should only be submitted to the FSA not the issuer Annex: Notification of major interests in sharesxxii

A: Identity of the persons or legal entity subject to the notification

obligation Full name

(including legal form of legal entities)

Contact address

(registered office for legal entities)

Phone number & email Other useful information

(at least legal representative for legal persons)

B: Identity of the notifier, if applicable

Full name Contact address Phone number & email Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

XLON
Date   Source Headline
6th Oct 20107:00 amRNSForm 8.3 - Silence Therapeutics Plc
5th Oct 20102:08 pmRNSForm 8.3 - Silence Therapeutics PLC
4th Oct 20107:00 amRNSMP Healthcare Form 8.3 - Silence Therapeutics Plc
1st Oct 20103:19 pmRNSForm 8.3 - Silence Therapeutics plc
1st Oct 20107:00 amRNSForm 8.3 - Silence Therapeutics
30th Sep 20101:48 pmRNSForm 8.3 - [Silence Therapeutics]
29th Sep 20107:00 amPRNForm 8.3 - Silence Therapeutics plc
23rd Sep 20102:45 pmPRNForm 8.3 - Silence Therapeutics Plc
22nd Sep 20102:42 pmPRNForm 8.3 - Silence Therapeutics plc
21st Sep 20101:38 pmRNSForm 8.3 - Silence Therapeutics
20th Sep 20107:00 amRNSHalf Yearly Report
15th Sep 20102:54 pmPRNForm 8.3 - Silence Therapeutics plc
15th Sep 20107:00 amRNSMP Healthcare Form 8.3 - Silence Therapeutics Plc
14th Sep 20103:12 pmPRNForm 8.3 - Silence Therapeutics
14th Sep 201011:22 amRNSForm 8.3 - Silence Therapeutics plc
14th Sep 20109:45 amRNSForm 8.5 (EPT/NON-RI)
14th Sep 20107:00 amRNSChange of Adviser
13th Sep 20101:45 pmRNSForm 8.5 (EPT/NON-RI)
10th Sep 20103:24 pmRNSMP Healthcare Form 8.3 - Silence Therapeutics Plc
10th Sep 20102:06 pmRNSForm 8 (OPD) - Silence Therapeutics plc
10th Sep 201011:19 amRNSForm 8.5 (EPT/NON-RI)
9th Sep 201011:48 amRNSForm 8.5 (EPT/NON-RI)
8th Sep 20104:23 pmRNSForm 8.5 - Silence Therapeutics PLC
8th Sep 20103:12 pmPRNForm 8.3 - Silence Therapeutics PLC
8th Sep 20102:43 pmRNSForm 8.3 - SILENCE THERAPEUTICS PLC
8th Sep 20101:35 pmRNSForm 8.3 - [Silence Therapeutics Plc Amendment]
8th Sep 20101:02 pmRNSForm 8.3 - Silence Therapeutics plc
8th Sep 20101:00 pmRNSForm 8.3 - Silence Therapeutics Plc
8th Sep 201012:42 pmRNSForm 8.3 - [Silence Therapeutics Plc)
8th Sep 201011:09 amRNSForm 8.5 (EPT/NON-RI)
8th Sep 20107:00 amRNSNon Regulatory - Patent Issuance
7th Sep 20103:13 pmRNSForm 8.3 - Silence Therapeutics Plc
7th Sep 20102:41 pmRNSForm 8.3 - Silence Therapeutics plc
7th Sep 20102:39 pmPRNForm 8.3 - Silence Therapeutics Plc
7th Sep 201012:46 pmRNSForm 8.3 - Silence Therapeutics plc
7th Sep 201012:19 pmRNSForm 8.5 - Silence Therapeutics Plc (amendment)
7th Sep 201011:53 amRNSForm 8.5 - Silence Therapeutics
7th Sep 201010:58 amRNSForm 8.5 (EPT/NON-RI)
6th Sep 20104:40 pmRNSSecond Price Monitoring Extn
6th Sep 20104:35 pmRNSPrice Monitoring Extension
6th Sep 20103:14 pmRNSPotential Offer
19th Aug 20104:35 pmRNSExclusive option agreement with Novartis
18th Aug 20107:00 amRNSChange of Auditor and Notice of Interim Results
11th Aug 20107:00 amRNSZamore Patent Issuance
14th Jul 20102:32 pmRNSHolding(s) in Company
14th Jul 20107:00 amRNSCollaboraton extension with AstraZeneca
9th Jul 20104:35 pmRNSPrice Monitoring Extension
18th Jun 201012:51 pmPRNAll Resolutions Passed at Silence's (AIM: SLN) AGM
11th May 20107:00 amPRNSilence (AIM:SLN) to Present at Investor Conferences
29th Apr 20107:00 amPRNFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.